IPC
BRLI

Independent Portfolio Consultants’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Independent Portfolio Consultants’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-105
Closed -$4K – 1103
2015
Q1 		$4K Hold
105
– – ﹤0.01% 796
2014
Q4 		$3K Buy
+105
New +$3.04K ﹤0.01% 762
2013
Q3 		– Sell
-9,345
Closed -$269K – 462
2013
Q2 		$269K Buy
+9,345
New +$258K 0.12% 364

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Independent Portfolio Consultants's BRLI Position: Q2 2015 in Review

Independent Portfolio Consultants sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 105 shares — an estimated $4K sold.

Independent Portfolio Consultants first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $269K in Q2 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Independent Portfolio Consultants reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 105 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $4K.
  • Independent Portfolio Consultants first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • Independent Portfolio Consultants's BIO-REFERENCE LABS INC-NEW- position peaked at $269K in Q2 2013.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Independent Portfolio Consultants's 13F filing for Q2 2015, filed 27 Jul 2015.